compound; guanfacine prodrug and its use; method for reducing gastrointestinal side effects associated with guanfacin therapy in a mammal; Methods of treating an attention deficit hyperactivity disorder and hypertension in a mammal
Prodrugs of guanfacine, pharmaceutical compositions containing such prodrugs and a method for providing therapeutic benefit in the treatment of ADHD/ODD (attention deficient hyperactivity disorder and oppositional defiance disorder) with guanfacine prodrugs are provided herein. Additionally, methods for improving the pharmacokinetics of guanfacine or minimizing or avoiding the adverse gastrointestinal side effects associated with guanfacine administration are provided herein.